The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|7|642-649

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.7, 2008-03, pp. : 642-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases

By Fotsch Christopher   Askew Ben C   Chen Jian Jeffrey  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 289-303

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

By Walker Brian R   Seckl Jonathan R  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 771-783

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents

By Webster Scott Peter   Pallin Thomas David  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 12, 2007-12 ,pp. : 1407-1422

Informa Healthcare

Access to resources Recommend Favorite

Substituted 1,2,4-oxodiazoles as Potent Inhibitors of Human 11bgr; - hydroxysteroid Dehydrogenase Type 1 (11bgr;-HSD1): Virtual Screening and Docking Results

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 3, 2016-03 ,pp. : 226-233

Bentham Science Publishers

Access to resources Recommend Favorite

Adrenal 11-beta hydroxysteroid dehydrogenase activity in response to stress

By Zallocchi Marisa   Matkovic Laura   Damasco María C  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 6, 2004-05 ,pp. : 422-425

NRC Research Press

Access to resources Recommend Favorite